Second Affiliated Hospital of Guangzhou Medical University · 1×
×8.410k/1kPHARM
×1.711k/6kONCOL
×0.76k/9kCR
×7.3872/120TRANS
×0.924k/26kMB
Citations per year
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
'26
Countries citing scholars working at PharmacoGenetics (China)
Since Specialization
Citations
This map shows the geographic impact of research produced by authors working at PharmacoGenetics (China). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at PharmacoGenetics (China) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PharmacoGenetics (China) more than expected).
Fields of papers published by authors at PharmacoGenetics (China)
This network shows the impact of papers affiliated with PharmacoGenetics (China) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with PharmacoGenetics (China) at the time of their publication.
About PharmacoGenetics (China)
In recent decades, authors affiliated with PharmacoGenetics (China) have published 2.1k papers, which have received a total of 67.6k indexed citations . Scholars at this organization have produced 327 papers in Pharmacology, 295 papers in Oncology, 160 papers in Cancer Research, 25 papers in Transplantation and 630 papers in Molecular Biology on the topics of Pharmacogenetics and Drug Metabolism (287 papers), Drug Transport and Resistance Mechanisms (166 papers), Cancer-related molecular mechanisms research (67 papers), Antibiotics Pharmacokinetics and Efficacy (56 papers), RNA modifications and cancer (56 papers), Pharmacological Effects and Toxicity Studies (45 papers), MicroRNA in disease regulation (41 papers) and Analytical Methods in Pharmaceuticals (40 papers). Their work is cited by papers focused on Pharmacology (10.2k citations), Oncology (11.2k citations), Cancer Research (5.9k citations), Transplantation (872 citations) and Molecular Biology (23.5k citations). Authors at PharmacoGenetics (China) collaborate with scholars in China, United States and United Kingdom and have published in prestigious journals including Pharmacogenetics and Genomics, British Journal of Clinical Pharmacology, Pharmacogenomics, Drug Metabolism and Disposition and The Journal of Immunology. Some of PharmacoGenetics (China)'s most productive authors include Leaf Huang, Zhaoqian Liu, Alexander S. Whitehead, Hong‐Hao Zhou, Clarissa Uhlar, Wen Xie, Ji‐Ye Yin, Wei Zhang, Magnus Ingelman‐Sundberg and Hong‐Hao Zhou.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.
Explore institutions with similar magnitude of impact